低劑量CT篩查的改進導致早期NSCLC診斷增加，而手術切除——通常為肺葉切除術或肺段切除術——仍是主要的治癒性選擇。然而在香港，患者經常伴有慢性呼吸系統疾病或心血管問題等共病，因此保留健康肺組織對其長期生活質素至關重要。
適應症：Lung Cancer (NSCLC)
收案條件
納入條件
- Age ≥18 years
- Histologically or cytologically confirmed stage IA NSCLC (T1N0M0, tumor ≤3 cm)
- Scheduled for surgical treatment (segmentectomy or lobectomy or robotic/navigation-guided bronchoscopic ablation)
- Ability to complete postoperative visits for up to 2 years
- Provided informed consent
排除條件
- Presence of lymph node involvement (N1 or higher) or distant metastases (M1)
- Concomitant primary malignancies that could confound outcome analysis
- Insufficient or missing key data points (e.g., tumor size, treatment type, survival status)
- Duplicate or overlapping records from different data sources
- Contraindications to anesthesia or sedation for bronchoscopy or surgery
- Inability or unwillingness to perform the PF tests
- Pregnant or breastfeeding women (for prospective phase)
- Inability or unwillingness to comply with study procedures
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。